Nitric oxide-releasing compounds inhibit the production of interleukin-2, -4 and -10 in activated human lymphocytes

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 4, 2008, Pages 322-328

  Korhonen, Riku ^b   Kosonen, Outi ^b   Hämäläinen, Mari ^b   Moilanen, Eeva ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 CHLORO 2 METHYLPHENYL) 5 (4 METHYLBENZENESULFONYLIMINO) 1,2,3,4 OXATRIAZOLE; 3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; CONCANAVALIN A; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; THAPSIGARGIN;

ARTICLE; CHEMICAL STRUCTURE; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL;

CELL CULTURE TECHNIQUES; CELLS, CULTURED; CONCANAVALIN A; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MOLECULAR STRUCTURE; NITRIC OXIDE; NITRIC OXIDE DONORS; RNA, MESSENGER; TH1 CELLS; TH2 CELLS;

EID: 52049095743     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00275.x     Document Type: Article

References (18)

1. Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005 4 : 471 79.
2. Zingarelli B, Hake PW, Yang Z, O'Connor M, Denenberg A, Wong HR. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage. FASEB J 2002 16 : 327 42.
3. Duhe RJ, Evans GA, Erwin RA, Kirken RA, Cox GW, Farrar WL. Nitric oxide and thiol redox regulation of janus kinase activity. Proc Natl Acad Sci USA 1998 95 : 126 31.
4. Gudi TF, Casteel DEF, Vinson CF, Boss GRF, Pilz RB. NO activation of fos promoter elements requires nuclear translocation of G-kinase I and CREB phosphorylation but is independent of MAP kinase activation. Oncogene 2000 19 : 6324 33.
5. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995 375 : 408 11.
6. Bauer H, Jung T, Tsikas D, Stichtenoth DO, Frolich JC, Neumann C. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology 1997 90 : 205 11.
7. Roozendaal R, Vellenga E, Postma DS, De Monchy JG, Kauffman HF. Nitric oxide selectively decreases interferon-gamma expression by activated human T lymphocytes via a cGMP-independent mechanism. Immunology 1999 98 : 393 9.
8. Kosonen O, Kankaanranta H, Lähde M, Vuorinen P, Ylitalo P, Moilanen E. Nitric oxide-releasing oxatriazole derivatives inhibit human lymphocyte proliferation by a cyclic GMP-independent mechanism. J Pharmacol Exp Ther 1998 286 : 215 20.
9. Kankaanranta H, Rydell E, Petersson AS, Holm P, Moilanen E, Corell T et al. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br J Pharmacol 1996 117 : 401 6.
10. Kosonen O, Kankaanranta H, Vuorinen P, Moilanen E. Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives. Eur J Pharmacol 1997 337 : 55 61.
11. Moilanen E, Vuorinen P, Kankaanranta H, Metsä-Ketelä T, Vapaatalo, H. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 1993 109 : 852 8.
12. Corell T, Pedersen SB, Lissau B, Moilanen E, Metsä-Ketelä T, Kankaanranta H et al. Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol J Pharmacol 1994 46 : 553 66.
13. Kosonen O, Kankaanranta H, Malo-Ranta U, Moilanen E. Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells. Eur J Pharmacol 1999 382 : 111 7.
14. Santucci L, Wallace J, Mencarelli A, Farneti S, Morelli A, Fiorucci S. Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis. Gastroenterology 2005 128 : 1243 57.
15. Cosen-Binker LI, Binker MG, Cosen R, Negri G, Tiscornia O. Influence of nitric oxide-donating nonsteroidal anti-inflammatory drugs on the evolution of acute pancreatitis. Shock 2006 25 : 190 203.
16. Taylor-Robinson AW. Counter-regulation of T helper 1 cell proliferation by nitric oxide and interleukin-2. Biochem Biophys Res Commun 1997 233 : 14 9.
17. Xiong Y, Karupiah G, Hogan SP, Foster PS, Ramsay AJ. Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J Immunol 1999 162 : 445 52.
18. Niedbala W, Cai B, Liu H, Pitman N, Chang L, Liew FY. Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc Natl Acad Sci USA 2007 104 : 15478 83.